CN102861269A - Drug combination for treating acne - Google Patents

Drug combination for treating acne Download PDF

Info

Publication number
CN102861269A
CN102861269A CN2012102381761A CN201210238176A CN102861269A CN 102861269 A CN102861269 A CN 102861269A CN 2012102381761 A CN2012102381761 A CN 2012102381761A CN 201210238176 A CN201210238176 A CN 201210238176A CN 102861269 A CN102861269 A CN 102861269A
Authority
CN
China
Prior art keywords
parts
pharmaceutical composition
drug combination
acne
radix
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN2012102381761A
Other languages
Chinese (zh)
Other versions
CN102861269B (en
Inventor
汪伟
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Qidong Huilong Vientiane Garden
Original Assignee
汪伟
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 汪伟 filed Critical 汪伟
Priority to CN 201210238176 priority Critical patent/CN102861269B/en
Publication of CN102861269A publication Critical patent/CN102861269A/en
Application granted granted Critical
Publication of CN102861269B publication Critical patent/CN102861269B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)

Abstract

The invention discloses a drug combination for treating acne, which is prepared with the following materials in parts by weight: 18 to 22 parts of honeysuckle, 18 to 22 parts of cicada slough, 10 to 15 parts of white mulberry root-bark, 10 to 15 parts of loquat leaf, 15 to 20 parts of glabrous greenbrier rhizome, 8 to 12 parts of divaricate saposhnikovia root, 12 to 18 parts of Chinese magnoliavine fruit, 10 to 20 parts of coix seed, 15 to 20 parts of heartleaf houttuynia herb, 5 to 15 parts of purslane herb, 25 to 30 parts of lily, 15 to 25 parts of Chinese yam and 20 to 30 parts of baical skullcap root. When the drug combination is used for treating acne, the course of treatment is short, the drug combination can rapidly take effect, the curative effect is good, the cure rate is high, and acne cannot easily recur.

Description

A kind of pharmaceutical composition of Acne treatment
Technical field
The present invention relates to a kind of pharmaceutical composition of Acne treatment, especially a kind of Chinese medicine composition of Acne treatment.
Background technology
Acne is a kind of chronic inflammatory disease illness of pilosebaceous unit structure, mainly betides face and thoracic dorsal etc. and locates, and shows as blackhead, inflammatory pimple, secondary pustule or tuberosity, cyst etc.Chinese medicine is called: " rosacea caused by lung-wind ", " pimples ", and how because of eating and drinking without temperance, surfeit delicious food savoury, the lung stomach is damp and hot, feels ailment said due to cold or exposure again and falls ill.After being apt to occur in buccal, chin, nose buccal groove, ear, chest, back and buttocks.After the adolescence, mostly naturally alleviate or fully recover.
Acne is apt to occur in and contains maximum, the abundantest sebaceous gland zone on the body skin, such as face, anterior part of chest, shoulder back and upper arm parts etc., how relevant with factors such as endocrine heredity, diet, spirit, but its Etiological pathology: the dyskeratosis of (1) follicular orifice causes follicular orifice to block.(2) androgen secretion too much stimulates responsive sebaceous gland, causes the sebaceous gland sebum secretion to increase, and the sebaceous gland cast that increases blocks follicular orifice; (3) propionic acid bacillus excessive multiplication in the hair follicle discharges too much multiple inflammatory material, makes hair follicle and hair follicle surrounding skin inflamed, forms pustule or acne cystica.Clinical pustule and tuberosity or cyst with hoary hair and blackhead, red pimple, suppuration.And inflammatory papular type and purulence papular type can cause erythema, pigmentation after the inflammation; the acne of nodular type, pustule type, cyst type and cicatrix type particularly; more often can stay the sequela such as pothole, Accretive Type cicatrix or keloid after, cause disfeaturing property consequence, cause repent forever.Acne belongs to motherland's medical science " pimples " category, thinks that the heart, lung meridian heat in blood pent up due to the face.
Acne treatment mainly for the reason of morbidity, at first will suppress the secretion of sebaceous gland at present, alleviates the follicular keratosis phenomenon, and it is unimpeded that skin is drained, and kills propionibacterium acnes again, cooperates anti-inflammatory drug to treat.General employing medicine for external use and oral medicine cooperate treats, and adds the medicine of vitamins and jointly adjusts endocrine.Present medicine on the market is very fast to the clinical symptom remission of acne, but long-term effect is not remarkable, and cure rate is low, and relapse rate is higher, does not reach too gratifying curative effect.
Summary of the invention
The objective of the invention is in order to provide a kind of short treating period, instant effect, good effect, the pharmaceutical composition of the Acne treatment of cure rate height and difficult recurrence.With medicine composite for curing acne of the present invention, short treating period, instant effect, good effect, the high and difficult recurrence of cure rate.
To achieve these goals, the present invention adopts following technical scheme: a kind of pharmaceutical composition of Acne treatment is formed by the preparation of raw material of following weight portion:
Flos Lonicerae 18-22 part, Periostracum Cicadae 18-22 part, Cortex Mori 10-15 part, Folium Eriobotryae 10-15 part, native Siberian cocklebur Siberian cocklebur 15-20 part,
Radix Saposhnikoviae 8-12 part, Fructus Schisandrae Chinensis 12-18 part, Semen Coicis 10-20 part, Herba Houttuyniae 15-20 part, Herba Portulacae 5-15 part,
Bulbus Lilii 25-30 part, Rhizoma Dioscoreae 15-25 part, Radix Scutellariae 20-30 part.
Aforementioned pharmaceutical compositions is the prestige by the preparation of raw material of following weight portion preferably:
20 parts of Flos Loniceraes, 18 parts of Periostracum Cicadaes, 12 parts of Cortex Mori, 10 parts of Folium Eriobotryaes, 20 parts of native Siberian cocklebur Siberian cockleburs,
12 parts of Radix Saposhnikoviaes, 12 parts of Fructus Schisandrae Chinensis, 20 parts of Semen Coiciss, 15 parts of Herba Houttuyniae, 12 parts of Herba Portulacaes,
25 parts of Bulbus Liliies, 20 parts of Rhizoma Dioscoreaes, 20 parts of Radix Scutellariaes.
Aforementioned pharmaceutical compositions can be made into pharmaceutically acceptable dosage form, such as water preparation, and granule, capsule or tablet etc.
Clinical observation:
Case quantity 500 examples.Age 15-45 year, 25 years old mean age.The course of disease is the longest 25 years, the shortest half a year.Male's 318 examples wherein; Women's 182 examples adopt medicine composite for curing of the present invention, and concrete parts by weight are finely tuned in the above-mentioned composition scope according to patient's physical condition.Therefore the almost non-toxic side effect of pharmaceutical composition of the present invention, until recovery from illness generally can be fully recovered in 2-4 week, is followed up a case by regular visits to after 5 months at fixing course for the treatment of not.
Diagnostic criteria:
Clinical condition of illness: face, the shirtfront, the back, hoary hair, blackhead, red pimple appear in the position skins such as upper arm, or purulence pimple or pustule.Clamp enter a profession tuberosity or cyst type tuberosity, struvite erythema appears in the lesions position skin, tuberosity, and inflammation pigmentation or cicatrix occur after eliminating, and whole body shows as oily skin.
Sign: whole skin is greasy, and the struvite tuberosity tenderness of projection is obvious, the focus surface irregularity.
(1) recovery from illness: the pars affecta skin full recovery is normal, with the zero difference (the cicatrix pigmentations that the indivedual healings of depolarization stay disappear outer not yet fully) relatively of healthy skin on every side.Skin surface is smooth, and smegma obviously reduces.
(2) effective: pars affecta skin surface pimple, relatively there is obvious minimizing to alleviate before tuberosity and cyst and the treatment, the lesions position pustule, purulence pimple and struvite pimple significantly alleviate.Leave obvious pigmentation or pothole, hypertrophic cicatrix and keloid after the part healing.
(3) invalid: ill skin focus relatively increases the weight of without alleviating or having with treatment is front, or again recurrence more.
Type of effect Case (sum 500) Ratio
Recovery from illness 482 96.4%
Effectively 15 3%
Invalid 3 0.6%
The specific embodiment
Embodiment 1
Flos Lonicerae 20g, Periostracum Cicadae 18g, Cortex Mori 12g, Folium Eriobotryae 10g, native Siberian cocklebur Siberian cocklebur 20g, Radix Saposhnikoviae 12g, Fructus Schisandrae Chinensis 12g, Semen Coicis 20g, Herba Houttuyniae 15g, Herba Portulacae 12g, Bulbus Lilii 25g, Rhizoma Dioscoreae 20g, Radix Scutellariae 20g decocts with water and makes decoction, three times on the one.
Embodiment 2
Flos Lonicerae 18g, Periostracum Cicadae 20g, Cortex Mori 12g, Folium Eriobotryae 12g, native Siberian cocklebur Siberian cocklebur 18g, Radix Saposhnikoviae 12g, Fructus Schisandrae Chinensis 15g, Semen Coicis 12g, Herba Houttuyniae 18g, Herba Portulacae 10g, Bulbus Lilii 25g, Rhizoma Dioscoreae 18g, Radix Scutellariae 20g pulverizes, and granulates, and sieves granulation agent, three times on the one.
Embodiment 3
Flos Lonicerae 18g, Periostracum Cicadae 20g, Cortex Mori 12g, Folium Eriobotryae 12g, native Siberian cocklebur Siberian cocklebur 18g, Radix Saposhnikoviae 12g, Fructus Schisandrae Chinensis 15g, Semen Coicis 12g, Herba Houttuyniae 18g, Herba Portulacae 10g, Bulbus Lilii 25g, Rhizoma Dioscoreae 18g, Radix Scutellariae 20g pulverizes, and is encapsulated, three times on the one.
Should be noted that above-described embodiment only is for example of the present invention clearly is described, and be not limitation of the invention.For those of ordinary skill in the field, can also make on the basis of the above description other multi-form variation or changes.And the apparent variation of being amplified out thus or change still are among protection scope of the present invention.

Claims (4)

1. the pharmaceutical composition of an Acne treatment is characterized in that, described pharmaceutical composition is formed by the preparation of raw material of following weight portion:
Flos Lonicerae 18-22 part, Periostracum Cicadae 18-22 part, Cortex Mori 10-15 part, Folium Eriobotryae 10-15 part, native Siberian cocklebur Siberian cocklebur 15-20 part,
Radix Saposhnikoviae 8-12 part, Fructus Schisandrae Chinensis 12-18, Semen Coicis 10-20 part, Herba Houttuyniae 15-20 part, Herba Portulacae 5-15 part,
Bulbus Lilii 25-30 part, Rhizoma Dioscoreae 15-25 part, Radix Scutellariae 20-30 part.
2. the pharmaceutical composition of Acne treatment is as claimed in claim 1 formed by the preparation of raw material of following weight portion:
20 parts of Flos Loniceraes, 18 parts of Periostracum Cicadaes, 12 parts of Cortex Mori, 10 parts of Folium Eriobotryaes, 20 parts of native Siberian cocklebur Siberian cockleburs,
12 parts of Radix Saposhnikoviaes, Fructus Schisandrae Chinensis 12,20 parts of Semen Coiciss, 15 parts of Herba Houttuyniae, 12 parts of Herba Portulacaes,
25 parts of Bulbus Liliies, 20 parts of Rhizoma Dioscoreaes, 20 parts of Radix Scutellariaes.
3. such as each described pharmaceutical composition of claim 1-2, described pharmaceutical composition can be made into pharmaceutically acceptable dosage form.
4. pharmaceutical composition as claimed in claim 3, wherein pharmaceutically acceptable dosage form is selected from water preparation, granule, capsule or tablet.
CN 201210238176 2012-06-30 2012-06-30 Drug combination for treating acne Active CN102861269B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN 201210238176 CN102861269B (en) 2012-06-30 2012-06-30 Drug combination for treating acne

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN 201210238176 CN102861269B (en) 2012-06-30 2012-06-30 Drug combination for treating acne

Publications (2)

Publication Number Publication Date
CN102861269A true CN102861269A (en) 2013-01-09
CN102861269B CN102861269B (en) 2013-10-09

Family

ID=47440584

Family Applications (1)

Application Number Title Priority Date Filing Date
CN 201210238176 Active CN102861269B (en) 2012-06-30 2012-06-30 Drug combination for treating acne

Country Status (1)

Country Link
CN (1) CN102861269B (en)

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101224287A (en) * 2007-12-27 2008-07-23 佟家勇 Oral administration Chinese traditional medicine for treating acne and preparing method thereof
CN102228532A (en) * 2011-06-24 2011-11-02 赤峰鼎基生物工程科技有限公司 Composite medicament for treating acne

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101224287A (en) * 2007-12-27 2008-07-23 佟家勇 Oral administration Chinese traditional medicine for treating acne and preparing method thereof
CN102228532A (en) * 2011-06-24 2011-11-02 赤峰鼎基生物工程科技有限公司 Composite medicament for treating acne

Also Published As

Publication number Publication date
CN102861269B (en) 2013-10-09

Similar Documents

Publication Publication Date Title
CN103341145B (en) Traditional Chinese medicine for treating psoriasis and preparation method thereof
CN103463539A (en) Drug for treating eczema, and preparation method and use thereof
CN103432244A (en) Composition having acne removing function
CN103690658B (en) A kind of Chinese medicine composition for the treatment of blood stasis type hemorrhoid
CN103520566B (en) Chinese medicinal cream for treating acnes
CN110585413A (en) Chinese medicinal plaster for treating infantile common cold, cough, abdominal pain and diarrhea, and its preparation method
CN104740320A (en) Traditional Chinese medicine composition for treating acne and preparation method thereof
CN102861269B (en) Drug combination for treating acne
CN102784234B (en) Traditional Chinese medicine composition for treating chronic urticaria
CN104721349A (en) Xiao Cuo Ling (acne remover) traditional Chinese medicine composition and preparation method thereof
CN104689132A (en) Traditional Chinese medicine composition for treating psoriasis
CN103638335A (en) Traditional Chinese medicine for treating refractory acne and preparation method thereof
CN104306641A (en) Traditional Chinese medicine composition for treating damp-heat type haemorrhoids
CN104055959A (en) Traditional Chinese medicine lotion and nursing method for treating gastrointestinal dampness-heat type seborrhoeic dermatitis
CN103006833B (en) Medicine for hiatus hernia postoperative rehabilitation
CN104474405A (en) Traditional Chinese medicine composition for treating chloasma
CN105250760A (en) Traditional Chinese medicine external lotion for treating infant eczema
CN102698061A (en) Chinese medicine for treating steaming bone and consumptive fever
CN103816539B (en) Medicinal composition containing aminolevulinic acid
CN102836366A (en) External liquid liniment for treating acnes
CN103599391B (en) The Chinese medicine composition of a kind of therapeutic radiation pneumonia
CN103705746B (en) A kind of external traditional Chinese medicinal application treating acne vulgaris
CN103720853B (en) A kind of Chinese medicine composition for the treatment of blood stasis type hemorrhoid
CN105381177A (en) External use traditional Chinese medicine for treating sweet stains
CN103735717B (en) A kind of medicine of speckle removing, acne removing

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
ASS Succession or assignment of patent right

Owner name: QIDONG HUILONG WANXIANG FLOWER NURSERY

Free format text: FORMER OWNER: WANG WEI

Effective date: 20140709

C41 Transfer of patent application or patent right or utility model
COR Change of bibliographic data

Free format text: CORRECT: ADDRESS; FROM: 404600 FENGJIE, CHONGQING TO: 226299 NANTONG, JIANGSU PROVINCE

TR01 Transfer of patent right

Effective date of registration: 20140709

Address after: Qidong huilongzhen 54 226299 villages in Jiangsu province Nantong City Service Center (south side)

Patentee after: Qidong Huilong Vientiane Garden

Address before: 4, unit 150, 404600 Choi Choi Street, Yongan Town, Fengjie County, Chongqing, 4-1

Patentee before: Wang Wei